share_log

B. Riley Securities Maintains Neutral on Rigel Pharmaceuticals, Maintains $1.25 Price Target

Moomoo 24/7 ·  Mar 6 08:37

B. Riley Securities analyst Kalpit Patel maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and maintains $1.25 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment